Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Phase 1, First-in-Human, Open-Label, Dose Escalation and Expansion Study of CUE-101 Monotherapy in Patients with HPV+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Multiple Cancer Types

Head/Neck, Phase I
I
Gibson, Mike
NCT03978689
VICCPHI1981

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: